Carisma Therapeutics (CARM) Institutional Ownership $0.40 +0.08 (+25.59%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$0.38 -0.03 (-6.69%) As of 09/5/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Carisma Therapeutics (NASDAQ:CARM)CurrentInstitutional OwnershipPercentage44.27%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$1.26MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$33.14K Get CARM Insider Trade Alerts Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CARM Institutional Buying and Selling by Quarter Carisma Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Jane Street Group LLC150,810$59K0.0%N/A0.361% 5/6/2025 Universal Beteiligungs und Servicegesellschaft mbH200,000$62K0.0%N/A0.479% 2/17/2025 Millennium Management LLC120,157$50K0.0%-15.7%0.288% 2/13/2025 Renaissance Technologies LLC231,357$97K0.0%+11.9%0.554% 11/19/2024 Barclays PLC549,305$539K0.0%+3,661,933.3%1.316% 11/16/2024 Geode Capital Management LLC259,184$254K0.0%-8.5%0.621% 11/15/2024 Barclays PLC549,305$539K0.0%+3,661,933.3%1.316% 11/15/2024 Wexford Capital LP34,861$34K0.0%+75.5%0.083% 9/16/2024 Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063% 8/15/2024 Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063% Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024 TPG GP A LLC842,031$1.28M0.0%-42.0%2.027% 8/9/2024 Renaissance Technologies LLC139,360$212K0.0%-38.3%0.335% 5/10/2024 Vanguard Group Inc.1,579,961$3.59M0.0%+0.7%3.803% 5/7/2024 Empowered Funds LLC26,984$61K0.0%-43.9%0.065% 2/14/2024Trustees of The University of Pennsylvania1,252,107$3.67M10.3%-28.9%3.102% 10/13/2023 SG Americas Securities LLC13,653$58K0.0%N/A0.034% 9/21/2023 Barclays PLC5,312$47K0.0%N/A0.013% 8/4/2023 American International Group Inc.12,834$113K0.0%N/A0.032% 7/27/2023EA Series Trust40,434$355K0.0%N/A0.100% 6/15/2023Trustees of The University of Pennsylvania2,182,812$6.77M6.6%N/A5.422% 5/15/2023 Wittenberg Investment Management Inc.46,703$145K0.1%N/A0.459% 5/12/2023 Deuterium Capital Management LLC51,256$159K0.2%N/A0.504% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.14,796$46K0.0%N/A0.145% 5/3/2023 Jump Financial LLC17,542$54K0.0%N/A0.172% 5/1/2023 Virtu Financial LLC15,335$48K0.0%N/A0.151% 4/27/2023 Stratos Wealth Partners LTD.19,899$62K0.0%N/A0.195% 4/24/2023 Blodgett Wealth Advisors LLC29,660$92K0.1%N/A0.291% 4/14/2023 BML Capital Management LLC411,398$1.28M1.1%N/A4.041% (Data available from 1/1/2016 forward) CARM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CARM shares? During the previous two years, 13 institutional investors and hedge funds held shares of Carisma Therapeutics. The most heavily invested institutionals were Trustees of The University of Pennsylvania ($3.67M), Vanguard Group Inc. ($3.59M), TPG GP A LLC ($1.28M), Barclays PLC ($539K), Geode Capital Management LLC ($254K), Renaissance Technologies LLC ($97K), and Universal Beteiligungs und Servicegesellschaft mbH ($62K).Learn more on Carisma Therapeutics' institutional investors. What percentage of Carisma Therapeutics' stock is owned by institutional investors? 44.27% of Carisma Therapeutics' stock is owned by institutional investors. Learn more on CARM's institutional investor holdings. Which institutional investors have been buying Carisma Therapeutics' stock? The following institutional investors have purchased Carisma Therapeutics' stock in the last 24 months: Barclays PLC ($1.10M), Universal Beteiligungs und Servicegesellschaft mbH ($200K), Jane Street Group LLC ($150.81K), Point72 Asia Singapore Pte. Ltd. ($52.01K), Renaissance Technologies LLC ($24.60K), Wexford Capital LP ($15K), and SG Americas Securities LLC ($13.65K). How much institutional buying is happening at Carisma Therapeutics? Institutional investors have bought a total of 1,514,996 shares in the last 24 months. This purchase volume represents approximately $1.26M in transactions. Which of Carisma Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Carisma Therapeutics stock in the last 24 months: Geode Capital Management LLC ($24.22K), and Millennium Management LLC ($22.37K). How much institutional selling is happening at Carisma Therapeutics? Institutional investors have sold a total of 46,589 shares in the last 24 months. This volume of shares sold represents approximately $33.14K in transactions. Related Companies Evogene Major Shareholders CalciMedica Major Shareholders Mersana Therapeutics Major Shareholders Exicure Major Shareholders OnKure Therapeutics Major Shareholders Reviva Pharmaceuticals Major Shareholders Xilio Therapeutics Major Shareholders Mural Oncology Major Shareholders Estrella Immunopharma Major Shareholders Hyperion DeFi Major Shareholders This page (NASDAQ:CARM) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CARM Stock Alerts